Expert Consensus on Hormonal Shifts in Multiple Sclerosis Care
A panel of experts has published a clinical opinion on managing age-related sex hormone changes and hypogonadism in patients with multiple sclerosis (MS). Published in *Neurology Clinical Practice*, the article synthesizes current knowledge on how hormonal fluctuations may interact with MS pathophysiology and symptoms. The expert opinion aims to guide neurologists and other clinicians in recognizing and addressing these endocrine factors, which are often overlooked in standard neurological care, to optimize long-term patient management and quality of life.
Why it might matter to you: For anesthesiologists, this highlights a critical comorbidity that can influence perioperative planning and anesthetic management in a complex patient population. Understanding the systemic endocrine implications of MS may inform decisions regarding hemodynamic stability, medication interactions, and postoperative recovery strategies. It underscores the importance of a holistic preoperative assessment that extends beyond the primary neurological diagnosis.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
